US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Latest News about Cardiology

Recent news which mentions Cardiology

2026 AAHFN CME Symposium - Practical Management of Transthyretin Cardiac Amyloidosis
Tickers CME
Tags New Jersey Cme Event
From PRLog
2026 AAHFN CME Symposium - New Opportunities with Mineralocorticoid Receptor Antagonists to Improve Outcomes in Heart Failure
Tickers CME
Tags New Jersey Cme Event
From PRLog
2025 HFSA CME Symposium - Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient Outcomes
Tickers CME
Tags Meded HFSA2025 Medical
From PRLog
2025 ISC CME Symposium - Best Practices for Managing Intracerebral Hemorrhage
Tickers ISC
Tags Cardio #intracerebral Hemorrhage
From PRLog
2024 AHA CME Symposium - Managing Hyperkalemia in Heart Failure: Overcoming Roadblocks with Best Practices
Tickers CME
Tags Heartfailure Cardiology United States
From PRLog
2024 HFSA CME Symposium - From Evidence to Practice: Treating Iron Deficiency with Intravenous Iron in Heart Failure
Tickers CME
Tags Event IViron Cme
From PRLog
2024 HFSA CME Symposium - Mastering the Dynamics of Worsening HFrEF: An In-Depth Approach to Effective Management
Tickers CME
Tags Education Atlanta Hfsa2024
From PRLog
2024 HFMC CME Symposium - Managing Worsening Heart Failure with Reduced Ejection Fraction: Strategies for Successful Outcomes
Tickers CME
Tags Education Reducedejectionfraction Meded
From PRLog
VALFIX Medical Inc. Secures Fifth Consecutive Grant from the Israel Innovation Authority
Tags Delaware Israel Health
From PRLog
2023 AHA CME Symposium - Translating Clinical Trials to Clinical Practice: Improving HF Outcomes with Intravenous Iron
Tickers CME HF IRON
Tags Medical United States Cardiology
From PRLog
VALFIX Medical Inc. Appoints Surindra N. Mitruka, MD, MBA, as New Board Member
Tags Mitral repair United States Medical Device
From PRLog
Elixia Announces New Hire Sam Searcy as Chief Commercial Officer
Tags North Carolina Technology Clinical Trials
From PRLog
CME Symposium- Anticoagulant Reversal in Stroke: Best Practices for Successful Outcomes
Tags Anticoagulant Emergency Medicine Cardiology
From PRLog
The Institute of Plant Based Medicine Announces it is Gearing Up for Group Experiences That Address Stress During the Upcoming Holidays
Tags Fitness Weight Loss Mental Health
From PRLog
CME Symposium- Case Challenges with #Antiplatelet Therapy
Tickers ACS PCI
Tags Education Event Cardiologist
From PRLog
CME Symposium- Managing Patients with Recent Worsening #HeartFailure with Reduced Ejection Fraction: Keys to Successful Outcomes
Tags Medical Cardiovascular United States
From PRLog
CME Symposium- Fine-Tuning the Management of Patients with #WorseningHeartFailure with Reduced Ejection Fraction
Tickers CME
Tags Heart Failure Cardiovascular HFSA
From PRLog
CME Symposium- Bridging the Gap Between Evidence and Clinical Practice: Improving Outcomes with #SGLT2Inhibitors in Patients with #HeartFailure
Tickers CME
Tags Medical HFSA Cardiovascular
From PRLog
The Institute of Plant Based Medicine Announces Two Exciting Weight Loss Programs That are Currently Pending FDA Approval
Tags Medical Newport Beach Cardiology
From PRLog
VALFIX Medical Receives its Fourth Consecutive Grant from the Israel Innovation Authority
Tags Heart Failure Mitral Valve Medical
From PRLog
VALFIX Medical Inc. Announces the Appointment of Former Abbott Ventures DVP, Evan Norton as New Independent Board Member
Tags TMVR Delaware Health
From PRLog
Rhythm Therapeutics rebrands as Inomagen Therapeutics
Tickers AFIB
Tags afib Atrial Fibrillation cardiology
From PRUnderground